US Stock MarketDetailed Quotes

RGBP REGEN BIOPHARMA INC

Watchlist
  • 0.379
  • -0.001-0.29%
15min DelayClose Jul 31 16:00 ET
1.56MMarket Cap-1578P/E (TTM)

REGEN BIOPHARMA INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-294.64%-209.32K
-1,451.39%-162.34K
71.34%-173.92K
72.56%-23.41K
43.42%-87.01K
40.22%-53.04K
96.25%-10.46K
46.33%-606.92K
92.01%-85.29K
-140.56%-153.77K
Net income from continuing operations
-122.77%-122.47K
-121.38%-349.76K
-52.67%1.16M
-316.56%-325.03K
-100.15%-99.22K
99.92%-54.98K
-38.16%1.64M
136.12%2.44M
94.36%-78.03K
994.07%66.96M
Operating gains losses
----
----
----
----
--0
--0
---1.15K
-99.65%1.83K
----
----
Other non cash items
--4.34K
436,700.00%4.37K
114.22%249.72K
400.07%249.71K
--0
--0
-100.00%1
106.39%116.57K
344.62%49.94K
102.83%52.29K
Change In working capital
-4,807.59%-91.19K
98.91%-21.79K
38.53%-1.93M
185.99%50.76K
100.02%12.21K
-100.00%1.94K
35.08%-1.99M
-149.80%-3.14M
80.55%-59.03K
-864.58%-66.97M
-Change in receivables
-152.16%-27.43K
-110.03%-12.3K
817.15%254.27K
19.76%56.55K
181.92%22.58K
290.79%52.58K
544.76%122.58K
69.34%-35.46K
269.48%47.22K
16.28%-27.56K
-Change in prepaid assets
-89.24%200
-57.83%5K
21.79%20.95K
-47.04%-4.62K
77.19%11.86K
-72.66%1.86K
72.93%11.86K
135.72%17.2K
93.47%-3.14K
167,175.00%6.69K
-Change in payables and accrued expense
-314.15%-32.32K
64.67%32.27K
26.39%59.46K
-50.09%15.35K
-46.37%9.42K
-70.92%15.09K
136.86%19.6K
-86.59%47.04K
-64.12%30.75K
-58.83%17.56K
-Change in other current liabilities
----
----
29.23%-2.15M
--0
--0
-100.05%-35.95K
28.64%-2.12M
-171.29%-3.04M
63.65%-102.21K
-1,074.17%-66.94M
-Change in other working capital
0.00%-31.64K
-47.81%-46.77K
11.22%-111.43K
47.81%-16.51K
-1.11%-31.64K
-2.25%-31.64K
0.00%-31.64K
-106.79%-125.52K
1.09%-31.64K
-101.67%-31.29K
Cash from discontinued investing activities
Operating cash flow
-294.64%-209.32K
-1,451.52%-162.34K
71.34%-173.92K
72.56%-23.41K
29.65%-87.01K
55.36%-53.04K
96.25%-10.46K
46.33%-606.92K
92.01%-85.29K
-93.49%-123.68K
Investing cash flow
Cash flow from continuing investing activities
-94.95%25K
Net investment purchase and sale
----
----
----
----
----
----
----
-94.95%25K
----
----
Cash from discontinued investing activities
Investing cash flow
----
----
----
----
----
----
----
-94.95%25K
----
----
Financing cash flow
Cash flow from continuing financing activities
62.94%162.94K
165.8K
359.21%243.75K
28,707.62%143.75K
0
100K
0
-106.90%-94.04K
-99.96%499
0
Net issuance payments of debt
-125.00%-25K
---46.5K
359.21%243.75K
28,707.62%143.75K
--0
--100K
--0
-106.90%-94.04K
-99.96%499
--0
Net common stock issuance
--187.94K
--212.3K
----
----
----
----
--0
----
----
----
Cash from discontinued financing activities
Financing cash flow
62.94%162.94K
--165.8K
359.21%243.75K
28,707.62%143.75K
--0
--100K
--0
-106.90%-94.04K
-99.96%499
--0
Net cash flow
Beginning cash position
205.58%124.5K
136.38%121.04K
-92.96%51.2K
-99.38%692
-62.63%87.7K
-88.47%40.74K
-92.96%51.2K
--727.16K
-41.02%110.99K
--234.67K
Current changes in cash
-198.77%-46.38K
133.07%3.46K
110.33%69.83K
301.28%120.35K
29.65%-87.01K
139.52%46.96K
97.20%-10.46K
-192.96%-675.96K
-111.09%-59.79K
---123.68K
End cash Position
-10.93%78.11K
205.58%124.5K
136.38%121.04K
136.38%121.04K
-99.38%692
-62.63%87.7K
-88.47%40.74K
-92.96%51.2K
-92.96%51.2K
-41.02%110.99K
Free cash flow
-294.64%-209.32K
-1,451.52%-162.34K
71.34%-173.92K
72.56%-23.41K
29.65%-87.01K
55.36%-53.04K
96.25%-10.46K
46.33%-606.92K
92.01%-85.29K
-93.49%-123.68K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -294.64%-209.32K-1,451.39%-162.34K71.34%-173.92K72.56%-23.41K43.42%-87.01K40.22%-53.04K96.25%-10.46K46.33%-606.92K92.01%-85.29K-140.56%-153.77K
Net income from continuing operations -122.77%-122.47K-121.38%-349.76K-52.67%1.16M-316.56%-325.03K-100.15%-99.22K99.92%-54.98K-38.16%1.64M136.12%2.44M94.36%-78.03K994.07%66.96M
Operating gains losses ------------------0--0---1.15K-99.65%1.83K--------
Other non cash items --4.34K436,700.00%4.37K114.22%249.72K400.07%249.71K--0--0-100.00%1106.39%116.57K344.62%49.94K102.83%52.29K
Change In working capital -4,807.59%-91.19K98.91%-21.79K38.53%-1.93M185.99%50.76K100.02%12.21K-100.00%1.94K35.08%-1.99M-149.80%-3.14M80.55%-59.03K-864.58%-66.97M
-Change in receivables -152.16%-27.43K-110.03%-12.3K817.15%254.27K19.76%56.55K181.92%22.58K290.79%52.58K544.76%122.58K69.34%-35.46K269.48%47.22K16.28%-27.56K
-Change in prepaid assets -89.24%200-57.83%5K21.79%20.95K-47.04%-4.62K77.19%11.86K-72.66%1.86K72.93%11.86K135.72%17.2K93.47%-3.14K167,175.00%6.69K
-Change in payables and accrued expense -314.15%-32.32K64.67%32.27K26.39%59.46K-50.09%15.35K-46.37%9.42K-70.92%15.09K136.86%19.6K-86.59%47.04K-64.12%30.75K-58.83%17.56K
-Change in other current liabilities --------29.23%-2.15M--0--0-100.05%-35.95K28.64%-2.12M-171.29%-3.04M63.65%-102.21K-1,074.17%-66.94M
-Change in other working capital 0.00%-31.64K-47.81%-46.77K11.22%-111.43K47.81%-16.51K-1.11%-31.64K-2.25%-31.64K0.00%-31.64K-106.79%-125.52K1.09%-31.64K-101.67%-31.29K
Cash from discontinued investing activities
Operating cash flow -294.64%-209.32K-1,451.52%-162.34K71.34%-173.92K72.56%-23.41K29.65%-87.01K55.36%-53.04K96.25%-10.46K46.33%-606.92K92.01%-85.29K-93.49%-123.68K
Investing cash flow
Cash flow from continuing investing activities -94.95%25K
Net investment purchase and sale -----------------------------94.95%25K--------
Cash from discontinued investing activities
Investing cash flow -----------------------------94.95%25K--------
Financing cash flow
Cash flow from continuing financing activities 62.94%162.94K165.8K359.21%243.75K28,707.62%143.75K0100K0-106.90%-94.04K-99.96%4990
Net issuance payments of debt -125.00%-25K---46.5K359.21%243.75K28,707.62%143.75K--0--100K--0-106.90%-94.04K-99.96%499--0
Net common stock issuance --187.94K--212.3K------------------0------------
Cash from discontinued financing activities
Financing cash flow 62.94%162.94K--165.8K359.21%243.75K28,707.62%143.75K--0--100K--0-106.90%-94.04K-99.96%499--0
Net cash flow
Beginning cash position 205.58%124.5K136.38%121.04K-92.96%51.2K-99.38%692-62.63%87.7K-88.47%40.74K-92.96%51.2K--727.16K-41.02%110.99K--234.67K
Current changes in cash -198.77%-46.38K133.07%3.46K110.33%69.83K301.28%120.35K29.65%-87.01K139.52%46.96K97.20%-10.46K-192.96%-675.96K-111.09%-59.79K---123.68K
End cash Position -10.93%78.11K205.58%124.5K136.38%121.04K136.38%121.04K-99.38%692-62.63%87.7K-88.47%40.74K-92.96%51.2K-92.96%51.2K-41.02%110.99K
Free cash flow -294.64%-209.32K-1,451.52%-162.34K71.34%-173.92K72.56%-23.41K29.65%-87.01K55.36%-53.04K96.25%-10.46K46.33%-606.92K92.01%-85.29K-93.49%-123.68K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday+0.03%